HITIQ Limited (HIQ) operates in the healthcare equipment sector, developing an end to-end concussion management and athlete-safety technology platform. The Company's products support the identification, monitoring, and management of sport-related brain injury through smart mouthguards and analytics.
Find out what a historical investment in Hitiq Call 0.022 AUD Hitiq 30Dec2028 Opt Def would be worth today using our HIQOA stock calculator.
Buying HIQOA shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Hitiq Call 0.022 AUD Hitiq 30Dec2028 Opt Def in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in HIQOA
What is the ticker symbol of Hitiq Call 0.022 AUD Hitiq 30Dec2028 Opt Def?
The ticker symbol for Hitiq Call 0.022 AUD Hitiq 30Dec2028 Opt Def is HIQOA.
How much is one share of HIQOA?
One share of HIQOA is valued at $0.00 as of 20 November 2026.
What is the market capitalisation of Hitiq Call 0.022 AUD Hitiq 30Dec2028 Opt Def HIQOA?
As of 20 November 2026 Hitiq Call 0.022 AUD Hitiq 30Dec2028 Opt Def has a market cap of $4.64M.
What is the P/E ratio of HIQOA?
The Price to Earnings ratio of HIQOA is -0.09.
What is the Earnings Per Share of HIQOA?
The Earnings Per Share of HIQOA is -$0.01.
What is the 52-week high for Hitiq Call 0.022 AUD Hitiq 30Dec2028 Opt Def stock?
The Hitiq Call 0.022 AUD Hitiq 30Dec2028 Opt Def 52-week high stock price is $0.01.
What is the 52-week low for Hitiq Call 0.022 AUD Hitiq 30Dec2028 Opt Def stock?
The Hitiq Call 0.022 AUD Hitiq 30Dec2028 Opt Def 52-week low stock price is $0.00.
Can I buy HIQOA shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy HIQOA shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.